Munich Startup
2NA FISH

2NA FISH

Heterogeneous tumors contain few cancer cells (5-15%) and a variety of other cells, such as immune cells and fibroblasts. They are difficult to treat because current diagnostic methods put all these cell types into a “mixer” and t...

Founded2021
Business ModelB2B
Industry-
This content was machine translated.

About 2NA FISH

Heterogeneous tumors contain few cancer cells (5-15%) and a variety of other cells, such as immune cells and fibroblasts. They are difficult to treat because current diagnostic methods put all these cell types into a “mixer” and then try to measure biomarkers in the resulting “smoothie.” 2NA FISH aims to revolutionize therapy decisions in cancer by developing the first technology for spatial RNA measurement (“spatial transcriptomics”) for clinical cancer diagnostics. By measuring up to 50 RNAs per single cell in spatial context, we can create more precise and predictable diagnoses for cancer therapy decisions.

More like this

Discover more articles, startups, and events from the ecosystem

From the Lab to a Startup: Why Good Research Alone Is Not Enough
Ecosystem

From the Lab to a Startup: Why Good Research Alone Is Not Enough

20.08.26
10 Min.
2NA Fish secures fresh capital
Deals

2NA Fish secures fresh capital

14.01.26
2 Min.
2NA Fish: Scalable technology for cancer treatment
Interviews

2NA Fish: Scalable technology for cancer treatment

24.12.24
5 Min.